News

FendX Technologies Inc. to Present at the Emerging Growth Conference on April 4, 2024

Oakville, Ontario--(Newsfile Corp. - April 2, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or…

2 years ago

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRxâ„¢ in patients withrecurrent pericarditis, with topline results expected in…

2 years ago

Cantargia Publishes Data Highlighting the Potential of CAN10 in Atherosclerosis

LUND, SWEDEN / ACCESSWIRE / April 2, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported publication of…

2 years ago

Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs

Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel siteHOLMES CHAPEL,…

2 years ago

MedMira Reports Second Quarter Results FY2024

HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for…

2 years ago

FSD Pharma Announces Filing of Year-End 2023 Results

TORONTO, ON / ACCESSWIRE / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

2 years ago

GE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy

With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated…

2 years ago

Spok(R) Clinches 7th Consecutive Title for Leading Satisfaction in Clinical Communications & Messaging, 2024 Black Book Annual Customer Experience Survey

NEW YORK, NY / ACCESSWIRE / April 1, 2024 / Black Book conducted surveys among thousands of healthcare professionals from…

2 years ago

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

2 years ago

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

2 years ago